Xiaokui Gu

1.7k total citations · 1 hit paper
41 papers, 808 citations indexed

About

Xiaokui Gu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Xiaokui Gu has authored 41 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Internal Medicine. Recurrent topics in Xiaokui Gu's work include Atrial Fibrillation Management and Outcomes (20 papers), Renal and Vascular Pathologies (17 papers) and Venous Thromboembolism Diagnosis and Management (16 papers). Xiaokui Gu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (20 papers), Renal and Vascular Pathologies (17 papers) and Venous Thromboembolism Diagnosis and Management (16 papers). Xiaokui Gu collaborates with scholars based in United States, China and Norway. Xiaokui Gu's co-authors include James B. Froehlich, Eva Kline‐Rogers, Bruce H. Gray, Jeffrey W. Olin, Heather L. Gornik, Michael R. Jaff, J. Michael Bacharach, Christopher J. White, Robert D. McBane and Alan H. Matsumoto and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Xiaokui Gu

41 papers receiving 791 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The United States Registry for Fibromuscular Dysplasia

2012 305 citations Jeffrey W. Olin, James B. Froehlich et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaokui Gu United States	13	515	358	340	128	71	41	808
Guilherme Yazbek Brazil	20	241 0.5×	128 0.4×	236 0.7×	109 0.9×	44 0.6×	48	866
B. Luther Germany	12	406 0.8×	96 0.3×	394 1.2×	36 0.3×	112 1.6×	73	647
Emiliano Chisci Italy	18	827 1.6×	421 1.2×	395 1.2×	29 0.2×	209 2.9×	84	1.1k
Irwin V. Mohan Australia	14	536 1.0×	247 0.7×	256 0.8×	21 0.2×	60 0.8×	27	692
J.F. Fairhead United Kingdom	11	973 1.9×	603 1.7×	357 1.1×	39 0.3×	99 1.4×	19	1.2k
Michael Barron United States	10	248 0.5×	205 0.6×	147 0.4×	25 0.2×	18 0.3×	22	553
Anthony J. Salvian Canada	13	520 1.0×	344 1.0×	285 0.8×	113 0.9×	145 2.0×	22	798
Susan M. Begelman United States	12	212 0.4×	118 0.3×	278 0.8×	108 0.8×	18 0.3×	32	554
D. A. M. Odekerken Netherlands	10	1.0k 2.0×	522 1.5×	660 1.9×	422 3.3×	24 0.3×	14	1.4k
Thomas R. Wyss Switzerland	15	579 1.1×	624 1.7×	472 1.4×	22 0.2×	34 0.5×	52	1.1k

Countries citing papers authored by Xiaokui Gu

Since Specialization

Citations

This map shows the geographic impact of Xiaokui Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokui Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokui Gu more than expected).

Fields of papers citing papers by Xiaokui Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokui Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokui Gu. The network helps show where Xiaokui Gu may publish in the future.

Co-authorship network of co-authors of Xiaokui Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokui Gu. A scholar is included among the top collaborators of Xiaokui Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokui Gu. Xiaokui Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haymart, Brian, Xiaokui Gu, Stephanie W. Watts, et al.. (2022). Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin. Journal of Thrombosis and Thrombolysis. 55(1). 141–148. 5 indexed citations

Gu, Xiaokui, et al.. (2022). WORSE OUTCOMES IN OBESE YOUNG ADULTS HOSPITALIZED WITH COVID-19. Journal of the American College of Cardiology. 79(9). 2089–2089. 1 indexed citations

Gornik, Heather L., Xiaokui Gu, J. Michael Bacharach, et al.. (2021). Association of Fibromuscular Dysplasia and Pulsatile Tinnitus: A Report of the US Registry for Fibromuscular Dysplasia. Journal of the American Heart Association. 10(17). e021962–e021962. 6 indexed citations

Barnes, Geoffrey D., Yun Li, Xiaokui Gu, et al.. (2020). Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry‐based cohort study. Journal of Thrombosis and Haemostasis. 18(8). 2025–2030. 6 indexed citations

Kurlander, Jacob E., Xiaokui Gu, James M. Scheiman, et al.. (2019). Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement Initiative. Vascular Medicine. 24(2). 153–155. 10 indexed citations

Barnes, Geoffrey D., Eva Kline‐Rogers, Xiaokui Gu, et al.. (2018). Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed‐methods study. Research and Practice in Thrombosis and Haemostasis. 3(1). 79–84. 7 indexed citations

Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2017). Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Advances. 1(26). 2536–2540. 9 indexed citations

Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2017). The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease. Blood. 130. 220–220. 1 indexed citations

Haymart, Brian, Xiaokui Gu, Eva Kline‐Rogers, et al.. (2016). Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant. Journal of Thrombosis and Thrombolysis. 43(2). 283–288. 21 indexed citations

10.

Kadian‐Dodov, Daniella, Heather L. Gornik, Xiaokui Gu, et al.. (2016). Dissection and Aneurysm in Patients With Fibromuscular Dysplasia. Journal of the American College of Cardiology. 68(2). 176–185. 125 indexed citations

11.

Putnam, Andrew J., Xiaokui Gu, Brian Haymart, et al.. (2015). The changing characteristics of atrial fibrillation patients treated with warfarin. Journal of Thrombosis and Thrombolysis. 40(4). 488–493. 4 indexed citations

12.

Hughey, Andrew B., Geoffrey D. Barnes, Xiaokui Gu, et al.. (2014). WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION: COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOMES OF THE “REAL-WORLD” MICHIGAN ANTICOAGULATION QUALITY IMPROVEMENT INITIATIVE (MAQI2) REGISTRY TO THE RE-LY, ROCKET-AF, AND ARISTOTLE TRIALS. Journal of the American College of Cardiology. 63(12). A418–A418. 2 indexed citations

13.

Barnes, Geoffrey D., Xiaokui Gu, Brian Haymart, et al.. (2014). The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience. Thrombosis Research. 134(2). 294–299. 29 indexed citations

14.

Gu, Xiaokui, et al.. (2013). Abstract 12390: Understanding Patient Characteristics and Clinical Significance of Headaches in Patients With Fibromuscular Dysplasia: A Report of the United States Registry for Fibromuscular Dysplasia. Circulation. 128. 1 indexed citations

15.

Olin, Jeffrey W., James B. Froehlich, Xiaokui Gu, et al.. (2013). CLINICAL MANIFESTATIONS OF FIBROMUSCULAR DYSPLASIA VARY BY PATIENT SEX: A REPORT OF THE UNITED STATES REGISTRY FOR FIBROMUSCULAR DYSPLASIA. Journal of the American College of Cardiology. 61(10). E2053–E2053. 6 indexed citations

16.

Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2013). Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 37(2). 171–176. 12 indexed citations

17.

Poloskey, Stacey, Jeffrey W. Olin, James B. Froehlich, et al.. (2012). PHYSICAL EXAMINATION FINDINGS IN FIBROMUSCULAR DYSPLASIA: A REPORT OF THE UNITED STATES REGISTRY FOR FIBROMUSCULAR DYSPLASIA. Journal of the American College of Cardiology. 59(13). E2075–E2075. 2 indexed citations

18.

Olin, Jeffrey W., Xiaokui Gu, James B. Froehlich, et al.. (2012). PERIPHERAL ARTERY DISSECTION IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA: A REPORT FROM THE UNITED STATES FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY. Journal of the American College of Cardiology. 59(13). E2052–E2052. 1 indexed citations

19.

Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2012). Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 35(1). 10–14. 21 indexed citations

20.

Ramanath, Vijay S., Kim A. Eagle, Christoph Nienaber, et al.. (2011). The role of preoperative coronary angiography in the setting of type A acute aortic dissection: Insights from the International Registry of Acute Aortic Dissection. American Heart Journal. 161(4). 790–796.e1. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact